Kangaroo Care Cuts Mortality in Low Birth Weight Newborns

Share this content:
Kangaroo Care Cuts Mortality in Low Birth Weight Newborns
Kangaroo Care Cuts Mortality in Low Birth Weight Newborns

WEDNESDAY, Dec. 23, 2015 (HealthDay News) -- Kangaroo mother care (KMC) is associated with improved neonatal outcomes among infants of any birth weight or gestational age, according to a review published online Dec. 23 in Pediatrics.

Ellen O. Boundy, Sc.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a systematic review and meta-analysis to estimate the correlation between KMC and neonatal outcomes. Data were included from 124 studies involving infants of any birth weight or gestational age.

The researchers found that KMC correlated with 36 percent lower mortality among low birth weight newborns, compared with conventional care among those newborns who survived to receive KMC (relative risk, 0.64). KMC also correlated with reduced risks of neonatal sepsis, hypothermia, hypoglycemia, and hospital readmission (relative risks, 0.53, 0.22, 0.12, and 0.42, respectively). KMC was associated with increased exclusive breastfeeding (relative risk, 1.50). KMC was also associated with lower mean respiratory rate and pain measures in newborns and with higher oxygen saturation, temperature, and head circumference growth.

"KMC is protective against a wide variety of adverse neonatal outcomes and has not shown evidence of harm," the authors write. "This safe, low-cost intervention has the potential to prevent many complications associated with preterm birth and may also provide benefits to full-term newborns."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »